CellType
The agentic drug company. We simulate human biology.
CellType is a business in healthcare based in New York City, NY, USA.
Profile
CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.
As a business in healthcare, CellType is listed here with the public details available about it.
The business is associated with New York City, NY, USA.
The company is listed at the Winter 2026 stage of development.
Its team size is recorded as 2 employees.
Directory analysis
CellType is an agentic drug company headquartered in New York City that builds AI agents to run the full drug discovery pipeline on top of biological foundation models simulating human biology. The company has already discovered and validated a new cancer treatment signal and is collaborating with top‑tier pharmaceutical partners.
Positioning: By integrating AI agents with advanced biological simulation, CellType aims to accelerate drug discovery and development. Its early validation and pharma partnerships indicate a potentially significant role in the evolving AI‑driven therapeutics landscape.
Note: CellType focuses on AI‑driven, end‑to‑end drug discovery using biological foundation models.
Auto-generated directory analysis from public data · updated 8 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | New York City, NY, USA |
| Country | USA |
| Employees | 2 |
| Stage | Winter 2026 |
Website: www.celltype.com
Browse related
Create a free account